On June 25, the China National Intellectual Property Administration(CNIPA) issued a notice to increase fees in RMB for the international phase of PCT applications. According to the notice, international application documents of up to 30 pages will be charged 10350 yuan (+7.59%).
On June 15, AbbVie filed a lawsuit against BeiGene, claiming that BeiGene’s Brukinsa has infringed a patent on its blood cancer drug Imbruvica. The disputed patent, which relates to the "use of BTK inhibitors", was issued on June 13, just two days before AbbVie lodged the suit.
Chinese display makers CSOT, Tianma and Visionox have together joined BOE to file a trial for patent invalidation with the Patent Trial and Appeal Board (PTAB), according to news on June 18. The Chinese display manufacturers are specifically attacking one patented technology.
Huawei Technologies is seeking licensing fees from roughly 30 small to midsize Japanese companies for the use of patented technology, Nikkei said on June 18. A source at Huawei's Japan unit revealed that "talks are currently underway with about 30 Japanese telecom companies."
Two Chinese central government-owned enterprise subsidiaries， China Railway Hi-Tech Industry and China Railway Construction Heavy Industry, have filed patent litigations against each other in the field of shield machines in recent years, according to the latest report.
